MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (NASDAQ: SNBR) today reported record results for the year ended December 30, 2017, including fourth-quarter results which exceeded expectations.
“Our consumer innovation strategy delivered market share growth and accelerated returns in 2017,” said Shelly Ibach, president and chief executive officer of Sleep Number. “Consumers are embracing the sleep and wellness benefits of our revolutionary Sleep Number 360™ smart bed. We look forward to having our full line of smart beds in market by mid-year 2018 and continuing to advance our supply chain initiatives for greater efficiency.”
Fourth-quarter Statement of Operations Review
- Net sales increased 16% to $363 million, including a 12% comparable sales increase and 4 percentage points (ppt) of growth from stores opened in the last twelve months
- Operating income increased 31% to $20 million, or 5.5% of net sales, a 60 basis-point rate improvement versus the prior year’s fourth quarter
- Earnings per diluted share increased 56% to $0.39, including 6 cents of tax benefits primarily due to application of the Tax Cuts and Jobs Act enacted in December 2017
Full-year Statement of Operations Review
- Net sales increased 10% to $1.44 billion in 2017, including a 4% comparable sales gain and 7 ppt of growth from new stores
- Operating income increased 20% to $92 million, or 6.4% of net sales, a 60 basis-point rate improvement versus the prior year
- Earnings per diluted share increased 41% to $1.55, compared to $1.10 in 2016, including 6 cents of tax benefits primarily due to application of the Tax Cuts and Jobs Act enacted in December 2017
Cash Flows and Balance Sheet Review
- Operating cash flows increased 14% to a record $173 million, compared with $152 million in 2016
- Invested $60 million in capital expenditures, compared with $58 million in 2016, with $487 million invested in the business over the past six years in the form of capital expenditures and acquisitions
- Increased share repurchases 20% to $150 million in 2017, bringing total returns to shareholders to $488 million over the past six years; $465 million remains available under our share repurchase authorization
- Return on invested capital (ROIC) was 14.3% for the year, well above our weighted average cost of capital
- On February 14, 2018 we amended our revolving credit facility to increase our net aggregate availability from $153 million to $300 million. We maintained the accordion feature which allows us to increase the amount of the credit facility from $300 million to $450 million, subject to lenders' approval. The credit agreement matures in February 2023
Financial Outlook
The company expects to generate full-year
2018 earnings per diluted share of between $1.70 and $2.00, a 10% to 29%
increase versus full-year 2017 earnings per diluted share of $1.55. The
outlook assumes mid-to- high single digit sales growth for 2018. The
2018 outlook assumes an estimated effective income tax rate of 25%,
based on the new tax legislation enacted in December 2017. The company
anticipates 2018 capital expenditures to be approximately $50 million.
Our outlook contemplates a slow growth economy.
Conference Call Information
Management will host its
regularly scheduled conference call to discuss the company’s results at
5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To listen to the call, please
dial 800-593-9959 (international participants dial 517-308-9340) and
reference the passcode “Sleep.” To access the webcast, please visit the
investor relations area of the Sleep Number website at http://www.sleepnumber.com/eng/aboutus/InvestorRelations.cfm.
The webcast replay will remain available for approximately 60 days.
About Sleep Number Corporation
As the leader in sleep
innovation, Sleep Number Corporation delivers the best quality sleep
through effortless, adjustable comfort and biometric sleep tracking.
Sleep Number is a visionary in health and wellness, proving the
connection between quality sleep and wellbeing. With its SleepIQ®
technology platform, powering one of the most comprehensive databases of
biometric consumer sleep data in the world, Sleep Number is
fundamentally changing the way we monitor and manage health. To
experience better quality sleep, visit one of the over 550 Sleep Number®
stores located in all 50 states or SleepNumber.com. For additional
information, visit our newsroom and investor relations site.
Forward-looking Statements
Statements used in this news
release relating to future plans, events, financial results or
performance are forward-looking statements subject to certain risks and
uncertainties including, among others, such factors as current and
future general and industry economic trends and consumer confidence; the
effectiveness of our marketing messages; the efficiency of our
advertising and promotional efforts; our ability to execute our
company-controlled distribution strategy; our ability to achieve and
maintain acceptable levels of product and service quality, and
acceptable product return and warranty claims rates; our ability to
continue to improve and expand our product line; consumer acceptance of
our products, product quality, innovation and brand image; industry
competition, the emergence of additional competitive products, and the
adequacy of our intellectual property rights to protect our products and
brand from competitive or infringing activities; availability of
attractive and cost-effective consumer credit options; pending and
unforeseen litigation and the potential for adverse publicity associated
with litigation; our “just-in-time” manufacturing processes with minimal
levels of inventory, which may leave us vulnerable to shortages in
supply; our dependence on significant suppliers and our ability to
maintain relationships with key suppliers, including several sole-source
suppliers; the vulnerability of key suppliers to recessionary pressures,
labor negotiations, liquidity concerns or other factors; rising
commodity costs and other inflationary pressures; risks inherent in
global sourcing activities; risks of disruption in the operation of
either of our two primary manufacturing facilities; increasing
government regulations, which have added or may add cost pressures and
process changes to ensure compliance; the adequacy of our management
information systems to meet the evolving needs of our business and to
protect sensitive data from potential cyber threats; the costs,
distractions and potential disruptions to our business related to
upgrading our management information systems; our ability to attract,
retain and motivate qualified management, executive and other key
employees, including qualified retail sales professionals and managers;
and uncertainties arising from global events, such as terrorist attacks,
political unrest or a pandemic outbreak, or the threat of such events.
Additional information concerning these and other risks and
uncertainties is contained in the company’s filings with the Securities
and Exchange Commission (SEC), including the Annual Report on Form 10-K,
and other periodic reports filed with the SEC. The company has no
obligation to publicly update or revise any of the forward-looking
statements in this news release.
SLEEP NUMBER CORPORATION | ||||||||||||||||||
AND SUBSIDIARIES | ||||||||||||||||||
Consolidated Statements of Operations | ||||||||||||||||||
(unaudited – in thousands, except per share amounts) | ||||||||||||||||||
Three Months Ended | ||||||||||||||||||
December 30, | % of | December 31, | % of | |||||||||||||||
2017 |
Net Sales |
2016 |
Net Sales |
|||||||||||||||
Net sales | $ | 363,279 | 100.0 | % | $ | 313,445 | 100.0 | % | ||||||||||
Cost of sales | 142,475 | 39.2 | % | 115,963 | 37.0 | % | ||||||||||||
Gross profit | 220,804 | 60.8 | % | 197,482 | 63.0 | % | ||||||||||||
Operating expenses: | ||||||||||||||||||
Sales and marketing | 161,793 | 44.5 | % | 152,368 | 48.6 | % | ||||||||||||
General and administrative | 32,036 | 8.8 | % | 23,472 | 7.5 | % | ||||||||||||
Research and development | 6,856 | 1.9 | % | 6,330 | 2.0 | % | ||||||||||||
Total operating expenses | 200,685 | 55.2 | % | 182,170 | 58.1 | % | ||||||||||||
Operating income | 20,119 | 5.5 | % | 15,312 | 4.9 | % | ||||||||||||
Other expense, net | (209 | ) | (0.1 | %) | (136 | ) | 0.0 | % | ||||||||||
Income before income taxes | 19,910 | 5.5 | % | 15,176 | 4.8 | % | ||||||||||||
Income tax expense | 4,119 | 1.1 | % | 3,889 | 1.2 | % | ||||||||||||
Net income | $ | 15,791 | 4.3 | % | $ | 11,287 | 3.6 | % | ||||||||||
Net income per share – basic | $ | 0.40 | $ | 0.25 | ||||||||||||||
Net income per share – diluted | $ | 0.39 | $ | 0.25 | ||||||||||||||
Reconciliation of weighted-average shares outstanding: |
||||||||||||||||||
Basic weighted-average shares outstanding | 39,627 | 44,501 | ||||||||||||||||
Dilutive effect of stock-based awards | 1,037 | 869 | ||||||||||||||||
Diluted weighted-average shares outstanding | 40,664 | 45,370 | ||||||||||||||||
SLEEP NUMBER CORPORATION | ||||||||||||||||||
AND SUBSIDIARIES | ||||||||||||||||||
Consolidated Statements of Operations | ||||||||||||||||||
(unaudited – in thousands, except per share amounts) | ||||||||||||||||||
Twelve Months Ended | ||||||||||||||||||
December 30, | % of | December 31, | % of | |||||||||||||||
2017 |
Net Sales |
2016 |
Net Sales |
|||||||||||||||
Net sales | $ | 1,444,497 | 100.0 | % | $ | 1,311,291 | 100.0 | % | ||||||||||
Cost of sales | 547,150 | 37.9 | % | 501,131 | 38.2 | % | ||||||||||||
Gross profit | 897,347 | 62.1 | % | 810,160 | 61.8 | % | ||||||||||||
Operating expenses: | ||||||||||||||||||
Sales and marketing | 650,357 | 45.0 | % | 595,845 | 45.4 | % | ||||||||||||
General and administrative | 127,269 | 8.8 | % | 109,674 | 8.4 | % | ||||||||||||
Research and development | 27,806 | 1.9 | % | 27,991 | 2.1 | % | ||||||||||||
Total operating expenses | 805,432 | 55.8 | % | 733,510 | 55.9 | % | ||||||||||||
Operating income | 91,915 | 6.4 | % | 76,650 | 5.8 | % | ||||||||||||
Other expense, net | (877 | ) | (0.1 | %) | (717 | ) | (0.1 | %) | ||||||||||
Income before income taxes | 91,038 | 6.3 | % | 75,933 | 5.8 | % | ||||||||||||
Income tax expense | 25,961 | 1.8 | % | 24,516 | 1.9 | % | ||||||||||||
Net income | $ | 65,077 | 4.5 | % | $ | 51,417 | 3.9 | % | ||||||||||
Net income per share – basic | $ | 1.58 | $ | 1.11 | ||||||||||||||
Net income per share – diluted | $ | 1.55 | $ | 1.10 | ||||||||||||||
Reconciliation of weighted-average shares outstanding: |
||||||||||||||||||
Basic weighted-average shares outstanding | 41,212 | 46,154 | ||||||||||||||||
Dilutive effect of stock-based awards | 873 | 748 | ||||||||||||||||
Diluted weighted-average shares outstanding | 42,085 | 46,902 | ||||||||||||||||
SLEEP NUMBER CORPORATION | ||||||||
AND SUBSIDIARIES | ||||||||
Consolidated Balance Sheets | ||||||||
(unaudited – in thousands, except per share amounts) | ||||||||
subject to reclassification | ||||||||
December 30, | December 31, | |||||||
2017 | 2016 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 3,651 | $ | 11,609 | ||||
Accounts receivable, net of allowance for doubtful accounts of $714 and $884, respectively |
19,312 | 19,705 | ||||||
Inventories | 84,298 | 75,026 | ||||||
Prepaid expenses | 17,565 | 8,705 | ||||||
Other current assets | 27,665 | 23,282 | ||||||
Total current assets | 152,491 | 138,327 | ||||||
Non-current assets: | ||||||||
Property and equipment, net | 208,646 | 208,367 | ||||||
Goodwill and intangible assets, net | 77,588 | 80,817 | ||||||
Deferred income taxes | 2,625 | 4,667 | ||||||
Other non-current assets | 30,484 | 24,988 | ||||||
Total assets | $ | 471,834 | $ | 457,166 | ||||
Liabilities and Shareholders’ Equity | ||||||||
Current liabilities: | ||||||||
Borrowings under revolving credit facility | $ | 24,500 | $ | - | ||||
Accounts payable | 129,194 | 105,375 | ||||||
Customer prepayments | 27,767 | 26,207 | ||||||
Accrued sales returns | 19,270 | 15,222 | ||||||
Compensation and benefits | 34,602 | 19,455 | ||||||
Taxes and withholding | 24,234 | 23,430 | ||||||
Other current liabilities | 46,822 | 35,628 | ||||||
Total current liabilities | 306,389 | 225,317 | ||||||
Non-current liabilities: | ||||||||
Other non-current liabilities | 76,289 | 71,529 | ||||||
Total liabilities | 382,678 | 296,846 | ||||||
Shareholders’ equity: | ||||||||
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding |
- | - | ||||||
Common stock, $0.01 par value; 142,500 shares authorized, 38,813 and 43,569 shares issued and outstanding, respectively |
388 | 436 | ||||||
Additional paid-in capital | - | - | ||||||
Retained earnings | 88,768 | 159,884 | ||||||
Total shareholders’ equity | 89,156 | 160,320 | ||||||
Total liabilities and shareholders’ equity | $ | 471,834 | $ | 457,166 | ||||
SLEEP NUMBER CORPORATION | ||||||||||
AND SUBSIDIARIES | ||||||||||
Consolidated Statements of Cash Flows | ||||||||||
(unaudited - in thousands) | ||||||||||
subject to reclassification | ||||||||||
Twelve Months Ended | ||||||||||
December 30, | December 31, | |||||||||
2017 | 2016 | |||||||||
Cash flows from operating activities: | ||||||||||
Net income | $ | 65,077 | $ | 51,417 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||
Depreciation and amortization | 61,291 | 57,172 | ||||||||
Stock-based compensation | 15,763 | 11,961 | ||||||||
Net loss on disposals and impairments of assets | 249 | 27 | ||||||||
Excess tax benefits from stock-based compensation | - | (517 | ) | |||||||
Deferred income taxes | 2,042 | (1,640 | ) | |||||||
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable | 393 | 9,297 | ||||||||
Inventories | (9,272 | ) | 11,574 | |||||||
Income taxes | 1,697 | 25,119 | ||||||||
Prepaid expenses and other assets | (12,405 | ) | (2,195 | ) | ||||||
Accounts payable | 21,779 | (4,965 | ) | |||||||
Customer prepayments | 1,560 | (25,266 | ) | |||||||
Accrued compensation and benefits | 15,398 | 2,808 | ||||||||
Other taxes and withholding | (893 | ) | 2,723 | |||||||
Other accruals and liabilities | 9,928 | 14,130 | ||||||||
Net cash provided by operating activities | 172,607 | 151,645 | ||||||||
Cash flows from investing activities: | ||||||||||
Purchases of property and equipment | (59,829 | ) | (57,852 | ) | ||||||
Proceeds from sales of property and equipment | 36 | 92 | ||||||||
Investments in marketable debt securities | - | (5,968 | ) | |||||||
Proceeds from marketable debt securities | - | 21,053 | ||||||||
Decrease in restricted cash | 3,150 | - | ||||||||
Net cash used in investing activities | (56,643 | ) | (42,675 | ) | ||||||
Cash flows from financing activities: | ||||||||||
Net increase in short-term borrowings | 28,094 | 5,932 | ||||||||
Repurchases of common stock | (155,245 | ) | (126,693 | ) | ||||||
Proceeds from issuance of common stock | 3,241 | 2,298 | ||||||||
Excess tax benefits from stock-based compensation | - | 517 | ||||||||
Debt issuance costs | (12 | ) | (409 | ) | ||||||
Net cash used in financing activities | (123,922 | ) | (118,355 | ) | ||||||
Net decrease in cash and cash equivalents | (7,958 | ) | (9,385 | ) | ||||||
Cash and cash equivalents, at beginning of period | 11,609 | 20,994 | ||||||||
Cash and cash equivalents, at end of period | $ | 3,651 | $ | 11,609 | ||||||
SLEEP NUMBER CORPORATION | ||||||||||||||||||||
AND SUBSIDIARIES | ||||||||||||||||||||
Supplemental Financial Information | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||||
December 30, | December 31, | December 30, | December 31, | |||||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||||||
Percent of sales: | ||||||||||||||||||||
Retail | 91.7 | % | 91.0 | % | 91.7 | % | 91.0 | % | ||||||||||||
Online and phone | 7.7 | % | 7.9 | % | 7.0 | % | 6.7 | % | ||||||||||||
Wholesale/other | 0.6 | % | 1.1 | % | 1.3 | % | 2.3 | % | ||||||||||||
Total | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||||||
Sales change rates: | ||||||||||||||||||||
Retail comparable-store sales | 12 | % | 30 | % | 3 | % | 0 | % | ||||||||||||
Online and phone | 13 | % | 91 | % | 16 | % | 25 | % | ||||||||||||
Company-Controlled comparable sales change | 12 | % | 34 | % | 4 | % | 1 | % | ||||||||||||
Net opened/closed stores | 4 | % | 12 | % | 7 | % | 7 | % | ||||||||||||
Total Company-Controlled Channel | 16 | % | 46 | % | 11 | % | 8 | % | ||||||||||||
Wholesale/other | (35 | %) | 29 | % | (38 | %) | 5 | % | ||||||||||||
Total | 16 | % | 46 | % | 10 | % | 8 | % | ||||||||||||
Stores open: | ||||||||||||||||||||
Beginning of period | 553 | 527 | 540 | 488 | ||||||||||||||||
Opened | 6 | 15 | 36 | 72 | ||||||||||||||||
Closed | (3 | ) | (2 | ) | (20 | ) | (20 | ) | ||||||||||||
End of period | 556 | 540 | 556 | 540 | ||||||||||||||||
Other metrics: | ||||||||||||||||||||
Average sales per store ($ in 000's) 1 | $ | 2,420 | $ | 2,364 | ||||||||||||||||
Average sales per square foot 1 | $ | 920 | $ | 937 | ||||||||||||||||
Stores > $1 million net sales 1 | 98 | % | 98 | % | ||||||||||||||||
Stores > $2 million net sales 1 | 61 | % | 61 | % | ||||||||||||||||
Average revenue per mattress unit 2 | $ | 4,421 | $ | 4,093 | $ | 4,283 | $ | 4,046 | ||||||||||||
1 Trailing twelve months for stores open at least one year. |
||||||||||||||||||||
2 Represents Company-Controlled Channel total net sales divided by Company-Controlled Channel mattress units. | ||||||||||||||||||||
SLEEP NUMBER CORPORATION AND SUBSIDIARIES | ||||||||||||||||||
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) | ||||||||||||||||||
(in thousands) | ||||||||||||||||||
We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure: | ||||||||||||||||||
Three Months Ended | Trailing-Twelve Months Ended | |||||||||||||||||
December 30, | December 31, | December 30, | December 31, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||||
Net income | $ | 15,791 | $ | 11,287 | $ | 65,077 | $ | 51,417 | ||||||||||
Income tax expense | 4,119 | 3,889 | 25,961 | 24,516 | ||||||||||||||
Interest expense | 227 | 186 | 975 | 811 | ||||||||||||||
Depreciation and amortization | 15,237 | 14,564 | 61,077 | 56,910 | ||||||||||||||
Stock-based compensation | 3,954 | 2,689 | 15,763 | 11,961 | ||||||||||||||
Asset impairments | 20 | 43 | 244 | 74 | ||||||||||||||
Adjusted EBITDA | $ | 39,348 | $ | 32,658 | $ | 169,097 | $ | 145,689 | ||||||||||
Free Cash Flow | ||||||||||||||||||
(in thousands) | ||||||||||||||||||
Three Months Ended | Trailing-Twelve Months Ended | |||||||||||||||||
December 30, | December 31, | December 30, | December 31, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||||
Net cash (used in) provided by operating activities | $ | (3,447 | ) | $ | 6,384 | $ | 172,607 | $ | 151,645 | |||||||||
Subtract: Purchases of property and equipment | 22,216 | 19,083 | 59,829 | 57,852 | ||||||||||||||
Free cash flow | $ | (25,663 | ) | $ | (12,699 | ) | $ | 112,778 | $ | 93,793 | ||||||||
Note - Our Adjusted EBITDA calculation and our "free cash flow" data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. |
||||||||||||||||||
GAAP - generally accepted accounting principles in the U.S. | ||||||||||||||||||
SLEEP NUMBER CORPORATION AND SUBSIDIARIES |
||||||||||
Calculation of Return on Invested Capital (ROIC) |
||||||||||
(in thousands) |
||||||||||
ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures: |
||||||||||
Trailing-Twelve Months Ended | ||||||||||
December 30, |
December 31, |
|||||||||
Net operating profit after taxes (NOPAT) |
||||||||||
Operating income | $ | 91,915 | $ | 76,650 | ||||||
Add: Rent expense 1 | 74,019 | 67,416 | ||||||||
Add: Interest income | 97 | 94 | ||||||||
Less: Depreciation on capitalized operating leases 2 | (18,865 | ) | (17,185 | ) | ||||||
Less: Income taxes 3 | (48,970 | ) | (41,933 | ) | ||||||
NOPAT | $ | 98,196 | $ | 85,042 | ||||||
Average invested capital |
||||||||||
Total equity | $ | 89,156 | $ | 160,320 | ||||||
Less: Cash greater than target 4 | - | - | ||||||||
Add: Long-term debt 5 | - | - | ||||||||
Add: Capitalized operating lease obligations 6 | 592,152 | 539,328 | ||||||||
Total invested capital at end of period | $ | 681,308 | $ | 699,648 | ||||||
Average invested capital 7 | $ | 686,436 | $ | 699,576 | ||||||
Return on invested capital (ROIC) 8 | 14.3 | % | 12.2 | % | ||||||
1 Rent expense is added back to operating income to show the impact of owning versus leasing the related assets. |
||||||||||
2 Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets. |
||||||||||
3 Reflects annual effective income tax rates, before discrete adjustments, of 33.3% and 33.0% for 2017 and 2016, respectively. |
||||||||||
4 Cash greater than target is defined as cash, cash equivalents and marketable debt securities less customer prepayments in excess of $100 million. |
||||||||||
5 Long-term debt includes existing capital lease obligations, if applicable. |
||||||||||
6 A multiple of eight times annual rent expense is used as an estimate of capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency. |
||||||||||
7 Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances. |
||||||||||
8 ROIC equals NOPAT divided by average invested capital. |
||||||||||
Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. |
||||||||||
GAAP - generally accepted accounting principles in the U.S. |
||||||||||